Key cytoskeletal proteins that are also typically altered in AD such as stathmin 1 (Stmn1), microtubule-associated protein tau (Mapt), and microtubule-associated proteins 1b and 2 (Map1b, Map2) were decreased in their phosphorylation status, particularly at the higher dose. This evidence concerns the gene MAPT and Alzheimer disease.